White House Council Names Continuous Pharmaceutical Manufacturing an "Emerging Priority"

In a recently released report on priority areas in advanced manufacturing by President Obama's National Science and Technology Council, continuous pharmaceutical manufacturing as identified as one of five "Manufacturing Technology Areas of Emerging Priority." Continuous manufacturing for pharmaceuticals has been pioneered at Rutgers by Professors Fernando Muzzio and Marianthi Ierapetritou of the Department of Chemical and Biochemical Engineering and Alberto Cuitino of the Department of Mechanical and Aerospace Engineering.

The Center for Structured Organic Particulate Systems (C-SOPS) is the world’s largest academically-based research organization dedicated to modernizing pharmaceutical manufacturing and dosage forms. Founded in 2006, this National Science Foundation-funded Engineering Research Center (ERC) brings together a cross-disciplinary team of engineers and scientists to work closely with industry leaders and the FDA to improve the way pharmaceuticals, foods, and agriculture products are manufactured. The vision of C-SOPS is to become the national focal point for science-based development of structured organic particle-based products and their manufacturing processes.

Headquartered at Rutgers University, C-SOPS partners include the New Jersey Institute of TechnologyPurdue University, the University of Puerto Rico at Mayaguez, and more than 40 industrial consortium member companies

Read White House report here>>